HealthSouth is the leader in inpatient rehabilitation, with a clear path for organic facility growth, ongoing lease de-leveraging, and favorable tailwinds from an aging population. The company trades at 8x trailing EBITDA, despite delivering consistent 5% top-line growth and 25% EBITDA margins. A...
![](https://sumzero-prod.s3.amazonaws.com/public/uploads/blog_post/featured_HLS_fc85a54c90.jpg)
HealthSouth's Troubled Past Is Today's Buying Opportunity
Published: March 26, 2014